The CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb have agreed to voluntarily testify at a Senate hearing in February regarding high prescription drug prices in the US, negating the need for a planned subpoena. This decision came following Senator Bernie Sanders’s criticism of the executives for their initial refusal due to claimed lack of expertise.
Mustang Panda’s New LOTUSLITE Variant Targets India Banks, South Korea Policy Circles – The Hacker News
Mustang Panda’s New LOTUSLITE Variant Targets India Banks, South Korea Policy Circles The Hacker News
